News - Glenmark Pharmaceuticals


Current filters:

Glenmark Pharmaceuticals

Popular Filters

Glenmark gets $4 million milestone in Forest collaboration

Glenmark gets $4 million milestone in Forest collaboration


Indian drugmaker Glenmark Pharmaceuticals has informed the Stock Exchange today that the company through…

FinancialForest LaboratoriesGlenmark PharmaceuticalsInflammatory diseasesLicensingPharmaceutical

Mayne Pharma signs up deals to market Subacap in Europe


Australian drugmaker Mayne Pharma (ASX: MYX) says it has signed two marketing and distribution agreements…

DermatologicalsEuropeGlenmark PharmaceuticalsIsdinitraconazoleLicensingMarkets & MarketingMayne PharmaPharmaceuticalSubacap

Briefs: Glenmark challenges Bayer patent; FDA delays Merck & Co's sugammadex


Indian drugmaker Glenmark Generics confirms that it seeking US Food and Drug Administration approval…

BayerBridionDermatologicalsFinacea GelGenericsGlenmark PharmaceuticalsMerck & CoNeurologicalNorth AmericaPatentsPharmaceuticalRegulationsugammadex

ICDR rules in favor of Glenmark over Crofelemer


Indian drugmaker Glenmark Pharmaceuticals saw its shares rise 2.3% to 415 rupees yesterday after the…

crofelemerGastro-intestinalsGlenmark PharmaceuticalsLegalNapo PharmaceuticalsPharmaceutical

Salix files Crofelemer NDA as spat with Napo moves to Glenmark


USA-based Salix Pharmaceuticals (Nasdaq) said yesterday that it has submitted a New Drug Application…

crofelemerGastro-intestinalsGlenmark PharmaceuticalsLegalLicensingNapo PharmaceuticalsPharmaceuticalRegulationSalix Pharmaceuticals

Glenmark sells rights to Crohn’s drug to Sanofi for up to $613 million


In a second licensing deal between the companies, Indian drugmaker Glenmark Pharmaceuticals, through…

Anti-Arthritics/RheumaticsGlenmark PharmaceuticalsLicensingPharmaceuticalSanofi

Back to top